The Women’s Tennis Association (WTA) and Hologic have formed a partnership which sees the medical device company as the global title sponsor of the WTA Tour.
Aiming to achieve significant progress through a ‘shared vision of greater wellness and equality for women’, the multi-year collaboration has been named the “largest global sponsorship in WTA history” and Hologic’s first worldwide sponsorship..
“From the start, we knew Hologic was the right partner,” commented WTA President Micky Lawler. “As we embark on a new era of women breaking barriers and understanding how imperative our health is to reach our full potential, Hologic joins the WTA family at a pivotal time.
“Reflecting on the passion we both share for women’s equality around the world, I look forward to the meaningful change this partnership will spark for our athletes, sport, and fans.”
Furthemore, the organisation, which has a primary focus on improving women’s health and wellbeing, looks to champion women in tennis whilst ‘modernising’ their respective industries of healthcare and sports.
Hologic Chairman, President and CEO, Steve MacMillan, added: “Hologic and the WTA come together with a collective purpose as pioneering advocates for women. We are proud to stand with the WTA in its commitment to the highest integrity and values.”
The firm will be integrated into the WTA across all platforms, including net signage at all WTA tournaments and virtual advertising at WTA 1000 and 500 events.
As the official health partner of the WTA, Hologic becomes the founding partner of Hologic WTA Labs which is a WTA initiative focused on health innovation and research-based projects specific to female athletes.
“Ultimately, our partnership allows us to jointly raise the profile of women even higher and to share the importance of early detection and treatment with women across the world,” concluded MacMillan.
The partners have stated that they plan to announce more joint activities in the coming months.